These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 28428108
1. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma. Kim WY, Shim SH, Jung HY, Dong M, Kim SN, Lee SJ. Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108 [Abstract] [Full Text] [Related]
2. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient. Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O. Mod Pathol; 2011 Aug; 24(8):1146-55. PubMed ID: 21478826 [Abstract] [Full Text] [Related]
3. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary. Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M. Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452 [Abstract] [Full Text] [Related]
4. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma. Darb-Esfahani S, Kunze CA, Kulbe H, Sehouli J, Wienert S, Lindner J, Budczies J, Bockmayr M, Dietel M, Denkert C, Braicu I, Jöhrens K. Oncotarget; 2016 Jan 12; 7(2):1486-99. PubMed ID: 26625204 [Abstract] [Full Text] [Related]
5. Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma. Chan AM, Enwere E, McIntyre JB, Wilson H, Nwaroh C, Wiebe N, Ou Y, Liu S, Wiedemeyer K, Rambau PF, Grevers X, Morris DG, Neri P, Gilks CB, Visser F, Le N, Luo L, Cook LS, Köbel M. J Pathol Clin Res; 2020 Oct 12; 6(4):252-262. PubMed ID: 32391646 [Abstract] [Full Text] [Related]
6. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. Ritterhouse LL, Nowak JA, Strickland KC, Garcia EP, Jia Y, Lindeman NI, Macconaill LE, Konstantinopoulos PA, Matulonis UA, Liu J, Berkowitz RS, Nucci MR, Crum CP, Sholl LM, Howitt BE. Mod Pathol; 2016 Aug 12; 29(8):893-903. PubMed ID: 27150160 [Abstract] [Full Text] [Related]
7. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases. Tran TN, Selinger CI, Kohonen-Corish MR, McCaughan B, Kennedy C, O'Toole SA, Cooper WA. Clin Lung Cancer; 2016 Jan 12; 17(1):30-8.e1. PubMed ID: 26395411 [Abstract] [Full Text] [Related]
8. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors. Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA. Am J Surg Pathol; 2016 Mar 12; 40(3):302-12. PubMed ID: 26551621 [Abstract] [Full Text] [Related]
9. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases. Liang L, Jiang Y, Chen JS, Niu N, Piao J, Ning J, Zu Y, Zhang J, Liu J. Hum Pathol; 2016 Nov 12; 57():1-6. PubMed ID: 27349304 [Abstract] [Full Text] [Related]
11. Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas. Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O. Mod Pathol; 2012 Jan 12; 25(1):122-30. PubMed ID: 21983935 [Abstract] [Full Text] [Related]
12. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B. Virchows Arch; 2018 Oct 12; 473(4):463-470. PubMed ID: 30032361 [Abstract] [Full Text] [Related]
13. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis? Gupta M, Babic A, Beck AH, Terry K. Hum Pathol; 2016 Aug 12; 54():82-91. PubMed ID: 27068525 [Abstract] [Full Text] [Related]
14. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome. Lee HE, Kim MA, Lee HS, Jung EJ, Yang HK, Lee BL, Bang YJ, Kim WH. Br J Cancer; 2012 Jul 10; 107(2):325-33. PubMed ID: 22644302 [Abstract] [Full Text] [Related]
15. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. Lee MJ, Kim N, Choung HK, Choe JY, Khwarg SI, Kim JE. J Cancer Res Clin Oncol; 2016 Jan 10; 142(1):125-33. PubMed ID: 26141290 [Abstract] [Full Text] [Related]
16. Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma. Harel-Dassa K, Yedgar S, Tropé CG, Davidson B, Reich R. Hum Pathol; 2017 Apr 10; 62():115-121. PubMed ID: 28087476 [Abstract] [Full Text] [Related]
17. PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma. Chen H, Molberg K, Strickland AL, Castrillon DH, Carrick K, Jiang Q, Niu S, Rivera-Colon G, Gwin K, Hinson S, Lea J, Miller DS, Zheng W, Lucas E. Am J Surg Pathol; 2020 Aug 10; 44(8):1050-1060. PubMed ID: 32384321 [Abstract] [Full Text] [Related]
19. MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases. Ma S, Fan L, Liu Y, Wang Y, Yu K, Wang L, Fang N, Liu F, Guo S, Wang Z. Diagn Pathol; 2018 Aug 21; 13(1):56. PubMed ID: 30126419 [Abstract] [Full Text] [Related]
20. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases. Assem H, Rambau PF, Lee S, Ogilvie T, Sienko A, Kelemen LE, Köbel M. Am J Surg Pathol; 2018 Apr 21; 42(4):534-544. PubMed ID: 29309296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]